- Home
- CGEM vs ADV Comparison
CGEM vs ADV Comparison
Compare CGEM & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- ADV
- Stock Information
- Founded
- CGEM 2016
- ADV 1987
- Country
- CGEM United States
- ADV United States
- Employees
- CGEM N/A
- ADV N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- ADV Business Services
- Sector
- CGEM Health Care
- ADV Consumer Discretionary
- Exchange
- CGEM Nasdaq
- ADV Nasdaq
- Market Cap
- CGEM 530.0M
- ADV 428.1M
- IPO Year
- CGEM 2021
- ADV N/A
- Fundamental
- Price
- CGEM $7.87
- ADV $1.44
- Analyst Decision
- CGEM Strong Buy
- ADV Strong Buy
- Analyst Count
- CGEM 6
- ADV 1
- Target Price
- CGEM $28.17
- ADV $2.50
- AVG Volume (30 Days)
- CGEM 351.4K
- ADV 689.6K
- Earning Date
- CGEM 08-07-2025
- ADV 08-06-2025
- Dividend Yield
- CGEM N/A
- ADV N/A
- EPS Growth
- CGEM N/A
- ADV N/A
- EPS
- CGEM N/A
- ADV N/A
- Revenue
- CGEM N/A
- ADV $3,526,704,000.00
- Revenue This Year
- CGEM N/A
- ADV N/A
- Revenue Next Year
- CGEM N/A
- ADV N/A
- P/E Ratio
- CGEM N/A
- ADV N/A
- Revenue Growth
- CGEM N/A
- ADV N/A
- 52 Week Low
- CGEM $6.85
- ADV $1.04
- 52 Week High
- CGEM $21.01
- ADV $4.16
- Technical
- Relative Strength Index (RSI)
- CGEM 48.81
- ADV 54.54
- Support Level
- CGEM $7.29
- ADV $1.28
- Resistance Level
- CGEM $7.94
- ADV $1.67
- Average True Range (ATR)
- CGEM 0.39
- ADV 0.12
- MACD
- CGEM 0.01
- ADV 0.01
- Stochastic Oscillator
- CGEM 77.36
- ADV 66.67
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.